Arthrosamid®

Around 1 in every 5 people aged over 45 in England are affected by knee osteoarthritis. 

​

Arthrosamid® is a new type of treatment for knee osteoarthritis that offers patients an effective alternative to current therapies. It is a non-biodegradable hydrogel that is injected into the knee to cushion the joint and relieve pain. 

 

Arthrosamid® is the only intra-articular 2.5% injectable polyacrylamide hydrogel (iPAAG) treatment approved in Europe that is permanently integrated in the synovial tissue of the inner capsule decreasing joint stiffness, reducing pain and improving the function of the knee affected by osteoarthritis. The physical mode of action allows Arthrosamid to provide long- term relief for patients with knee OA.

​

https://arthrosamid.com/